Verified

OPERATING GRANT

International Organization For the Study of Inflammatory Bowel Disease

Grants to a maximum of Euro 200,000 for up to one year may be awarded; preferably equally divided between Clinical and Basic Science Projects. Preference will be given to grants less than or equal to Euro 50.000. No monies will be awarded to cover principle or co-investigators salaries. If institutions mandate that salaries of any size be included within any grant application, the investigator will have to come up with that money, but it will not be acceptable to include a salary line for principle or co investigators in the grant operating budget. Salaries can be included for research assistants, technicians, and trainees. Furthermore the IOIBD Foundation restricts diversion of a maximum of 10 percent of the IOIBD Grant funds by the host institution to cover indirect cost.

A short presentation of the project outcome is requested within 5 years after granting, during the annual general IOIBD meeting by the principal investigator.

Submitting applications by your junior faculty or as a joint-application with another / several institues is encouraged.

REVIEW OF APPLICATIONS
Applications will be reviewed by a grant review panel made up of members of the IOIBD. It will be at the discretion of this panel if they solicit external reviews. The final awarding of grants will be undertaken by the Executive Committee based on the recommendations of the grant review panel. If a member of the Executive Committee is applying for a grant he/she will not participate in the deliberations during the final grant awarding process.

The current Grant Review Committee is formed by the following members:
Gerhard Rogler (chair), Ashwin Ananthakrishnan, Dermot McGovern, and Harry Sokol
Members at large (executive team) will be added to the committee for the review process.

ETHICS
Clinical investigation
The IOIBD attaches great importance to the ethical acceptability of experiments involving human subjects. It is recognized that the investigator has a professional responsibility in this respect, and that the institution in which the research will be conducted must also make certain that the experiments are conducted in an ethical way. The IOIBD examines the ethical considerations as part of its review of each proposal, and funds will not be provided unless the protocol is entirely satisfactory.

The IOIBD requires that each clinical investigation project for which funds are sought from the Foundation be reviewed with regard to its acceptability on ethical grounds and approved by an institutional ethical review board. The Institutional Review Board approval must be submitted.

Similarly, appropriate approval for conduct of animal research must be submitted. Certification of care and use of experimental animals must be submitted.

Deadline: The submission deadline will be 01 September 2026

APPLICATIONS
Please submit the original copy of the application form electronically. It is a requirement to use the IOIBD Grant Application form, that can be requested with the IOIBD Scientific Secretariat: ioibd@mkproducties.nl
Each IOIBD member is allowed to submit only ONE application per year

All applications must include:

research objectives
review of literature
methodology
analytical methods/techniques
relevance of research to IBD and possible Impact on IBD care worldwide
budget
references/bibliography
list of currently held funding and pending grant applications
ethical approval for human experimentation
ethical approval for animal experimentation

AI Based Application Success Predictor

1. Direct relevance to inflammatory bowel disease (Highest Predictor ⭐⭐⭐⭐⭐)

This is the most important criterion.

Competitive proposals should focus on:

Crohn's disease
Ulcerative colitis
IBD pathogenesis
Intestinal inflammation
Mucosal immunology
Gut microbiome
IBD complications
Disease monitoring
Precision medicine in IBD

Projects outside IBD are generally not competitive.

2. Scientific excellence and innovation (Highest Predictor ⭐⭐⭐⭐⭐)

IOIBD prioritizes projects that:

Address major unanswered questions
Present original hypotheses
Use innovative methodologies
Advance understanding of IBD biology
Challenge existing paradigms

Innovative research capable of changing future clinical practice is highly valued.

3. Strong translational and clinical impact (Highest Predictor ⭐⭐⭐⭐⭐)

Successful proposals should demonstrate potential to:

Improve diagnosis
Optimize treatment selection
Predict disease progression
Personalize therapy
Improve long-term patient outcomes
Enhance quality of life

Research with a clear pathway from laboratory discoveries to patient care is particularly competitive.

4. Addressing high-priority unmet needs in IBD (Very High Predictor ⭐⭐⭐⭐⭐)

Projects aligned with internationally recognized research priorities are highly competitive, including:

Biomarkers for diagnosis and treatment response
Precision medicine
Disease prediction
Optimal therapeutic strategies
Microbiome research
Mucosal healing
Patient-reported outcomes
Comparative effectiveness research

These topics consistently appear among international IBD research priorities.

5. Rigorous methodology and feasibility (Very High Predictor ⭐⭐⭐⭐⭐)

Competitive applications include:

Clearly defined aims
Robust study design
Appropriate statistical methods
Realistic timelines
Feasible milestones
Strong preliminary rationale

Methodological quality is essential for successful peer review.

6. International and multidisciplinary collaboration (Very High Predictor ⭐⭐⭐⭐⭐)

IOIBD is an international organization and favors projects involving:

Gastroenterologists
Immunologists
Microbiologists
Surgeons
Pathologists
Bioinformaticians
Epidemiologists
Basic scientists
International research centers

Collaborative studies that combine complementary expertise are particularly competitive.

7. Investigator expertise and collaborative track record (Very High Predictor ⭐⭐⭐⭐⭐)

Reviewers evaluate:

Scientific publications
Previous IBD research
Leadership experience
Complementary expertise
Ability to execute complex collaborative projects

A strong multidisciplinary team increases confidence in successful project completion.

8. Patient-centered outcomes and quality of life (High Predictor ⭐⭐⭐⭐☆)

IOIBD increasingly supports research addressing:

Fatigue
Pain
Quality of life
Functional outcomes
Shared decision-making
Patient-reported outcome measures

Projects that directly address issues important to patients are viewed favorably.

9. Potential to influence clinical guidelines and practice (High Predictor ⭐⭐⭐⭐☆)

Competitive proposals should demonstrate potential to:

Inform international guidelines
Improve standards of care
Generate evidence for treatment recommendations
Change clinical decision-making

Research with broad clinical applicability is highly valued.

10. Dissemination and future research potential (High Predictor ⭐⭐⭐⭐☆)

Successful applications include plans to:

Publish in high-impact journals
Present findings at international meetings
Share data where appropriate
Generate preliminary data for larger multicenter studies
Foster future international collaborations

Projects that strengthen the global IBD research community receive additional consideration.

Specialties

Cardiovascular Diseases

Clinical Trials

Eligibility Requirements

Applicants MUST have an active or senior IOIBD member as PI or co-investigator.
Any travel or operating grants will be awarded to the IOIBD member so that they are responsible to see that the project is undertaken and completed.
Money will be transferred to the institution where the IOIBD members is employed.
The IOIBD Foundation restricts diversion of a maximum of 10 percent of the IOIBD Grant funds by the host institution to cover indirect cost.
An Institution that has been succesfully granted in 2024 cannot submit an application in 2025.

Sponsor Details

Sponsor Institute/Organizations: International Organization For the Study of Inflammatory Bowel Disease

Sponsor Type: Corporate/Non-Profit

Address: Javalaan 9a 3742 CN Baarn

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity